Showing 5321-5330 of 9245 results for "".
The Mind-Skin Connection: Psoriasis and Psychological Comorbidities
https://practicaldermatology.com/issues/supplements/the-mind-skin-connection-psoriasis-and-psychological-comorbidities/20833/Which Probiotic for Which Disease? Part 1
https://practicaldermatology.com/topics/atopic-dermatitis/which-probiotic-for-which-disease-part-1/23550/Enhanced interest in probiotics means clinicians need to pick the best strain for common dermatologic conditions.Mechanism of Action Matters: A Review of New and Emerging Biologics
https://practicaldermatology.com/issues/supplements/mechanism-of-action-matters-a-review-of-new-and-emerging-biologics/23178/Targeting Cellulite: Evolving Approaches
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/targeting-cellulite-evolving-approaches/23796/New treatments mean that dermatologists can improve treatment outcomes for the 90% of women who have cellulite.Stirring the Pot: Cannabinoids and Atopic Dermatitis
https://practicaldermatology.com/topics/atopic-dermatitis/stirring-the-pot-cannabinoids-and-atopic-dermatitis/20565/Cannabinoids are a diverse group of compounds that may hold significant therapeutic capabilities applicable to many areas of medicine, including dermatology.New Frontiers in Skin Cancer Management
https://practicaldermatology.com/topics/skin-cancer-photoprotection/new-frontiers-in-skin-cancer-management/57249/Across the spectrum of diagnosis, prognostication, prevention, and treatment, advances in technology and therapeutics are reshaping how clinicians care for patients with skin cancer. This issue highlights innovations and insights that are changing the field and offers a glimpse of where skin cancerDupilumab For the Management of Pembrolizumab-induced Rash: A Case Report
https://practicaldermatology.com/youngmd-connect/resident-resource-center/dupilumab-for-the-management-of-pembrolizumab-induced-rash-a-case-report/23841/Biosimilar Medicines in Dermatology: Key Aspects
https://practicaldermatology.com/topics/psoriasis/biosimilar-medicines-in-dermatology-key-aspects/22929/After the recent enactment of a specific approval pathway for biosimilars and publication of the first draft guidelines on biosimilar product development by the FDA, biosimilars are expected to be available in the US soon.Incidental Invasive Melanoma Discovered During Excision Of Basal Cell Carcinoma: Implications For The Cutaneous Surgeon
https://practicaldermatology.com/topics/skin-cancer-photoprotection/incidental-invasive-melanoma-discovered-during-excision-of-basal-cell-carcinoma-implications-for-the-cutaneous-surgeon/23981/New in My Practice: Cosmeceutical
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/new-in-my-practice-cosmeceutical/23943/